New Results
Myeloid-specific KDM6B inhibition sensitizes Glioblastoma to PD1 blockade
Sangeeta Goswami, Deblina Raychaudhuri, Pratishtha Singh, Seanu Meena Natarajan, Yulong Chen, Candice Poon, Mercedes Hennessey, Jan Zhang, Swetha Anandhan, Brittany Parker Kerrigan, Marc D. Macaluso, Zhong He, Sonali Jindal, Frederick F. Lang, Sreyashi Basu, Padmanee Sharma
doi: https://doi.org/10.1101/2022.11.28.518243
Sangeeta Goswami
1Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas
2Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas
Deblina Raychaudhuri
1Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas
Pratishtha Singh
1Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas
Seanu Meena Natarajan
1Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas
Yulong Chen
3Immunotherapy Platform, The University of Texas MD Anderson Cancer Center, Houston, Texas
Candice Poon
4Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Mercedes Hennessey
1Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas
Jan Zhang
2Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas
Swetha Anandhan
2Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas
Brittany Parker Kerrigan
4Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Marc D. Macaluso
3Immunotherapy Platform, The University of Texas MD Anderson Cancer Center, Houston, Texas
Zhong He
3Immunotherapy Platform, The University of Texas MD Anderson Cancer Center, Houston, Texas
Sonali Jindal
3Immunotherapy Platform, The University of Texas MD Anderson Cancer Center, Houston, Texas
Frederick F. Lang
4Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Sreyashi Basu
3Immunotherapy Platform, The University of Texas MD Anderson Cancer Center, Houston, Texas
Padmanee Sharma
1Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas
2Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas
3Immunotherapy Platform, The University of Texas MD Anderson Cancer Center, Houston, Texas
Article usage
Posted November 29, 2022.
Myeloid-specific KDM6B inhibition sensitizes Glioblastoma to PD1 blockade
Sangeeta Goswami, Deblina Raychaudhuri, Pratishtha Singh, Seanu Meena Natarajan, Yulong Chen, Candice Poon, Mercedes Hennessey, Jan Zhang, Swetha Anandhan, Brittany Parker Kerrigan, Marc D. Macaluso, Zhong He, Sonali Jindal, Frederick F. Lang, Sreyashi Basu, Padmanee Sharma
bioRxiv 2022.11.28.518243; doi: https://doi.org/10.1101/2022.11.28.518243
Myeloid-specific KDM6B inhibition sensitizes Glioblastoma to PD1 blockade
Sangeeta Goswami, Deblina Raychaudhuri, Pratishtha Singh, Seanu Meena Natarajan, Yulong Chen, Candice Poon, Mercedes Hennessey, Jan Zhang, Swetha Anandhan, Brittany Parker Kerrigan, Marc D. Macaluso, Zhong He, Sonali Jindal, Frederick F. Lang, Sreyashi Basu, Padmanee Sharma
bioRxiv 2022.11.28.518243; doi: https://doi.org/10.1101/2022.11.28.518243
Subject Area
Subject Areas
- Biochemistry (11718)
- Bioengineering (8724)
- Bioinformatics (29132)
- Biophysics (14936)
- Cancer Biology (12051)
- Cell Biology (17360)
- Clinical Trials (138)
- Developmental Biology (9406)
- Ecology (14146)
- Epidemiology (2067)
- Evolutionary Biology (18269)
- Genetics (12223)
- Genomics (16768)
- Immunology (11844)
- Microbiology (28016)
- Molecular Biology (11560)
- Neuroscience (60822)
- Paleontology (450)
- Pathology (1864)
- Pharmacology and Toxicology (3231)
- Physiology (4940)
- Plant Biology (10401)
- Synthetic Biology (2878)
- Systems Biology (7333)
- Zoology (1642)